Vera Therapeutics Inc (VERA)

Currency in USD
42.43
-0.53(-1.23%)
Closed·
42.18-0.25(-0.59%)
·
Unusual trading volume
VERA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
40.6243.69
52 wk Range
19.0756.05
Key Statistics
Prev. Close
42.43
Open
42.95
Day's Range
40.62-43.69
52 wk Range
19.07-56.05
Volume
3.86M
Average Volume (3m)
1.51M
1-Year Change
75.2582%
Book Value / Share
7
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VERA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
81.79
Upside
+92.75%
Members' Sentiments
Bearish
Bullish
ProTips
4 analysts have revised their earnings downwards for the upcoming period

Vera Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Neutral
Moving Averages
Strong Buy

Analyst Ratings

13 Buy
1 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 81.79
(+92.75% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
TD Cowen
Buy78.00+83.83%73.00MaintainJul 08, 2026
Cantor Fitzgerald
Buy100.00+135.68%-MaintainJul 08, 2026
Guggenheim
Buy76.00+79.12%56.00MaintainJul 08, 2026
H.C. Wainwright
Buy125.00+194.60%110.00MaintainJul 08, 2026
Jefferies
Buy60.00+41.41%-MaintainJun 02, 2026

Earnings

Latest Release
May 07, 2026
EPS / Forecast
-1.69 / -1.33
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

VERA Income Statement

Compare VERA to Peers and Sector

Metrics to compare
VERA
Peers
Sector
Relationship
P/E Ratio
−8.3x−3.9x−0.4x
PEG Ratio
0.10−0.090.00
Price/Book
6.1x5.5x2.6x
Price / LTM Sales
-9.2x3.0x
Upside (Analyst Target)
93.3%59.6%51.9%
Fair Value Upside
Unlock−12.8%9.4%Unlock

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
27.01M37.63%1.15B
Other Institutional Investors
61.27M62.37%2.60B
Public Companies & Retail Investors
0.000.00%0.00
Total
88.28M100.00%3.75B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Avoro Capital Advisors LLC8.20%5,888,888249,866
Longitude Capital Management Co., LLC7.51%5,394,212228,876

People Also Watch

114.16
KYMR
-4.26%
37.96
IDYA
-6.29%
30.64
TNGX
+1.73%
18.870
ERAS
+2.78%
98.07
DNTH
+2.41%

FAQ

What Is the Vera Therapeutics (VERA) Stock Price Today?

The Vera Therapeutics stock price today is 42.43 USD.

What Stock Exchange Does Vera Therapeutics Trade On?

Vera Therapeutics is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Vera Therapeutics?

The stock symbol for Vera Therapeutics is "VERA."

What Is the Vera Therapeutics Market Cap?

As of today, Vera Therapeutics market cap is 3.05B USD.

What Is Vera Therapeutics's Earnings Per Share (TTM)?

The Vera Therapeutics EPS (TTM) is -5.57.

When Is the Next Vera Therapeutics Earnings Date?

Vera Therapeutics will release its next earnings report on Aug 06, 2026.

From a Technical Analysis Perspective, Is VERA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Vera Therapeutics Stock Split?

Vera Therapeutics has split 0 times.

How Many Employees Does Vera Therapeutics Have?

Vera Therapeutics has 339 employees.

What is the current trading status of Vera Therapeutics (VERA)?

As of Jul 09, 2026, Vera Therapeutics (VERA) is trading at a price of 42.43 USD, with a previous close of 42.43 USD. The stock has fluctuated within a day range of 40.62 USD to 43.69 USD, while its 52-week range spans from 19.07 USD to 56.05 USD.

What Is Vera Therapeutics (VERA) Price Target According to Analysts?

The average 12-month price target for Vera Therapeutics is 81.79 USD, with a high estimate of 125 USD and a low estimate of 43 USD. 13 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +92.75% Upside potential.

What Is the VERA Premarket Price?

VERA's last pre-market stock price is 42.18 USD. The pre-market share volume is 640.00, and the stock has decreased by -0.25, or -0.59%.

What Is the VERA After Hours Price?

VERA's last after hours stock price is 42.20 USD, the stock has decreased by -0.23, or -0.54%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.